Crossmark

Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group

Crossref DOI link: https://doi.org/10.1016/j.eimce.2016.02.004

Published Print: 2017-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Crespo, Manuel

Navarro, Jordi

Moreno, Santiago

Sanz, Jesus

Márquez, Manuel

Zamora, Javier

Ocampo, Antonio

Iribaren, Josèc) A.

Rivero, Antonio

Llibre, Josep M.
Funding

Funding for this research was provided by:

ViiV Healthcare
License Information

Text and Data Mining valid from 2017-10-01
More Information

This article is maintained by: Elsevier

Article Title: Hepatic safety of maraviroc in HIV-1-infected patients with hepatitis C and/or B co-infection. The Maraviroc Cohort Spanish Group

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2016.02.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2016.02.029

Content Type: article

Copyright: © 2016 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.